Ibsen P H, Holm A, Raaschou-Nielsen M, Petersen J W, Capiau C, Heron I
Statens Seruminstitut, Vaccine Department, Copenhagen, Denmark.
APMIS. 1992 Feb;100(2):159-69. doi: 10.1111/j.1699-0463.1992.tb00856.x.
Two peptides, designated L and K, covering a sequence near the NH-terminal end of the S1 subunit of pertussis toxin (PT) were conjugated to the PPD (purified protein derivative) of M. tuberculosis by either glutaraldehyde (GLUT) or succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) and N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) and injected into groups of mice and guinea pigs. Initially, the effect of priming the animals with BCG vaccine and the use of aluminium hydroxide as adjuvant for the anti-peptide antibody response was studied. The group of BCG-primed mice immunized with adsorbed peptide conjugates showed the highest anti-peptide conjugate antibody response. Based on this finding, groups of BCG-primed mice were immunized four times with either adsorbed peptide L-GLUT, peptide L-SMCC/SPDP or peptide K-SMCC/SPDP conjugates and the fine peptide specificity as well as the PT and S1 cross-reactivity was investigated in ELISA. Mice immunized with peptide L-GLUT showed a significant antibody response to the homologous conjugate, only, whereas the group injected with the peptide L-SMCC/SPDP conjugate gave a significant response to both peptide K and L conjugated by the SMCC-SPDP method. Likewise, mice immunized with the peptide K-SMCC/SPDP conjugate reacted with the homologous and peptide L-SMCC/SPDP conjugate, although only the response to the former conjugate was significantly greater than the response to PPD. All groups showed a strong anti-PPD response. The anti-PT/S1 cross-reactivity of the antisera varied considerably within each group but was found to be highest in the peptide L-GLUT-immunized animals. The results of the present study not only stress the importance of BCG priming and use of aluminium hydroxide adjuvants for the immunogenicity of the peptides in question but also point to the specificity of the conjugation methods employed as low cross-reactivity between the anti-peptide L-GLUT and L-SMCC/SPDP antisera was noted. Moreover, it appeared that the choice of conjugation method may have an effect on the ability of the peptide conjugates to induce an antibody response cross-reacting with the native protein.
两种肽,分别命名为L和K,覆盖百日咳毒素(PT)S1亚基NH末端附近的一段序列,通过戊二醛(GLUT)或4-(N-马来酰亚胺甲基)环己烷-1-羧酸琥珀酰亚胺酯(SMCC)以及N-琥珀酰亚胺基3-(2-吡啶二硫基)丙酸酯(SPDP)与结核分枝杆菌的纯化蛋白衍生物(PPD)偶联,并注射到几组小鼠和豚鼠体内。最初,研究了用卡介苗疫苗对动物进行初免以及使用氢氧化铝作为抗肽抗体反应佐剂的效果。用吸附的肽偶联物免疫的卡介苗初免小鼠组显示出最高的抗肽偶联物抗体反应。基于这一发现,用吸附的肽L-GLUT、肽L-SMCC/SPDP或肽K-SMCC/SPDP偶联物对卡介苗初免小鼠组进行了4次免疫,并在酶联免疫吸附测定(ELISA)中研究了精细肽特异性以及PT和S1交叉反应性。用肽L-GLUT免疫的小鼠仅对同源偶联物显示出显著的抗体反应,而注射肽L-SMCC/SPDP偶联物的组对通过SMCC-SPDP方法偶联的肽K和L均产生了显著反应。同样,用肽K-SMCC/SPDP偶联物免疫的小鼠与同源和肽L-SMCC/SPDP偶联物发生反应,尽管仅对前一种偶联物的反应明显大于对PPD的反应。所有组均显示出强烈的抗PPD反应。每组抗血清的抗PT/S1交叉反应性差异很大,但在肽L-GLUT免疫的动物中最高。本研究结果不仅强调了卡介苗初免和使用氢氧化铝佐剂对所研究肽的免疫原性的重要性,还指出了所采用偶联方法的特异性,因为抗肽L-GLUT和L-SMCC/SPDP抗血清之间的交叉反应性较低。此外,似乎偶联方法的选择可能会影响肽偶联物诱导与天然蛋白发生交叉反应的抗体反应的能力。